A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
AI-generated Family Guy stream banned after making a bomb threat
What happened during Adin Ross vs N3on? Internet brutally trolls streamers' 'cringe' boxing match: 'Kids fight better than these two'
Biden calls on US colleges to consider adversity during admission process
ChatGPT vs Bing vs Bard: You can pick the best in this chatbot arena
A $30 Billion Disaster Is Just the Tip of a Deadly Climate Cycle
HasanAbi takes dig at xQc and Amouranth for changing attitude over Kick deals, fans call it 'insanely uneven argument'
How big tech embraced disabled users
Microsoft Grabs More AI Power With OpenAI Board Seat